Duane Mitchell
Duane Mitchell
Phyllis Kottler Friedman Professor, University of Florida
Verified email at
Cited by
Cited by
Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma
JH Sampson, AB Heimberger, GE Archer, KD Aldape, AH Friedman, ...
Journal of clinical oncology 28 (31), 4722, 2010
Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma
PE Fecci, DA Mitchell, JF Whitesides, W Xie, AH Friedman, GE Archer, ...
Cancer research 66 (6), 3294-3302, 2006
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
DA Mitchell, KA Batich, MD Gunn, MN Huang, L Sanchez-Perez, SK Nair, ...
Nature 519 (7543), 366-369, 2015
Proteomic and immunologic analyses of brain tumor exosomes
MW Graner, O Alzate, AM Dechkovskaia, JD Keene, JH Sampson, ...
The FASEB Journal 23 (5), 1541, 2009
Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
DA Mitchell, W Xie, R Schmittling, C Learn, A Friedman, RE McLendon, ...
Neuro-oncology 10 (1), 10-18, 2008
Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function
PE Fecci, H Ochiai, DA Mitchell, PM Grossi, AE Sweeney, GE Archer, ...
Clinical cancer research 13 (7), 2158-2167, 2007
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
JH Sampson, KD Aldape, GE Archer, A Coan, A Desjardins, AH Friedman, ...
Neuro-oncology 13 (3), 324-333, 2011
An epidermal growth factor receptor variant III–targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
JH Sampson, GE Archer, DA Mitchell, AB Heimberger, JE Herndon, ...
Molecular cancer therapeutics 8 (10), 2773-2779, 2009
Long-term survival in glioblastoma with cytomegalovirus pp65-targeted vaccination
KA Batich, EA Reap, GE Archer, L Sanchez-Perez, SK Nair, ...
Clinical Cancer Research 23 (8), 1898-1909, 2017
CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
L Jin, H Tao, A Karachi, Y Long, AY Hou, M Na, KA Dyson, AJ Grippin, ...
Nature communications 10 (1), 4016, 2019
A large language model for electronic health records
X Yang, A Chen, N PourNejatian, HC Shin, KE Smith, C Parisien, ...
NPJ digital medicine 5 (1), 194, 2022
RNA-transfected dendritic cells in cancer immunotherapy
DA Mitchell, SK Nair
The Journal of clinical investigation 106 (9), 1065-1069, 2000
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
JA Flores-Toro, D Luo, A Gopinath, MR Sarkisian, JJ Campbell, IF Charo, ...
Proceedings of the National Academy of Sciences 117 (2), 1129-1138, 2020
Temozolomide for immunomodulation in the treatment of glioblastoma
A Karachi, F Dastmalchi, DA Mitchell, M Rahman
Neuro-oncology 20 (12), 1566-1572, 2018
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
JH Sampson, GE Archer, DA Mitchell, AB Heimberger, DD Bigner
Seminars in immunology 20 (5), 267-275, 2008
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
EJ Sayour, P McLendon, R McLendon, G De Leon, R Reynolds, J Kresak, ...
Cancer Immunology, Immunotherapy 64, 419-427, 2015
Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells
PE Fecci, AE Sweeney, PM Grossi, SK Nair, CA Learn, DA Mitchell, X Cui, ...
Clinical Cancer Research 12 (14), 4294-4305, 2006
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
CA von Roemeling, Y Wang, Y Qie, H Yuan, H Zhao, X Liu, Z Yang, ...
Nature communications 11 (1), 1508, 2020
Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma
BD Choi, CT Kuan, M Cai, GE Archer, DA Mitchell, PC Gedeon, ...
Proceedings of the National Academy of Sciences 110 (1), 270-275, 2013
EGFRvIII‐targeted vaccination therapy of malignant glioma
BD Choi, GE Archer, DA Mitchell, AB Heimberger, RE McLendon, ...
Brain pathology 19 (4), 713-723, 2009
The system can't perform the operation now. Try again later.
Articles 1–20